FDA Inspection 924994 — Aesica Formulation Development Ltd
The FDA completed an inspection of Aesica Formulation Development Ltd on Apr 29, 2015 in Nottingham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 29, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nottingham (United Kingdom)